The routine commissioning of botulinum toxin A is accepted in Devon for the management of blepharospasm when the condition causes the patient to be affected to at least a moderate degree by one or more of the criteria specified in the policy.
| Filename: | Botulinum Toxin A for the management of blepharospasm |
| Filetype: | |
| Filesize: | 101.66 KB |
| Date uploaded: | 1st March 2017 |
| Date updated: | 8th December 2022 |
